Rs 80,000 crore worth defence projects cleared, 6 submarines to be built in India

October 26, 2014

New Delhi, Oct 26: Defence projects worth a whopping Rs 80,000 crore were on Saturday cleared by the government which decided that six submarines will be made indigenously and over 8,000 Israeli antitank guided missiles and 12 upgraded Dornier surveillance aircraft will be purchased.

Defence-ministryThe decisions were taken following a meeting of the defence acquisition council, chaired by defence minister Arun Jaitley, that lasted for over two hours with defence secretary, the chiefs of all three services, DRDO chief and other senior officials attending it.

The bulk of the decisions went in favour of the Navy that was in dire need of up-gradation and capability enhancement.

The big ticket step was the decision to build six submarines in India at a cost of about Rs 50,000 crore rather than source it from outside.

The other major decision was to purchase 8,356 antitank guided missile of Israel worth Rs 3,200 crore rather than the US' Javelin missile for the Indian Army. The Army will also purchase 321 launchers for the missile.

Another 12 Dornier surveillance aircraft with enhanced sensors will also be bought from the Hindustan Aeronautics Ltd at a cost of Rs 1,850 crore.

The DAC also decided to buy 362 infantry fighting vehicle from the ordinance factory board, Medak in West Bengal for Rs 662 crore.

Giving details of the decision to make the six submarines in the country, official sources said a committee will now be formed by the defence ministry which will study both public and private shipyards over the next 6-8 weeks.

Following this, the ministry will issue request for proposal (RFP) to specific port that will be identified on the basis of the study which will look into whether they have the capacity and manpower to build six submarines in the same port only besides other parametres.

The submarines will be air independent propulsion (AIP) capable that will enable them to stay underwater for longer than a conventional submarine besides having enhanced stealth features.

The Navy currently has 13 operational submarines and the target set in 1999 was to have 24 by 2030.

The previous UPA government had gone in for six Scorpene submarines and the first is likely to be delivered only in 2016.

The decision to manufacture the submarines in India is in line with Prime Minister Narendra Modi's 'Make in India' pitch.

The submarines will have the capacity to be equipped with land attack cruise missiles.

The DAC also decided to buy 1,761 units of five spoke 7.5 tonne radio containers at the cost of Rs 662 crore besides acquiring 1,768 critical rolling stock — open and closed wagons for transport of military equipment at a cost of Rs 740 crore.

Both will go to domestic vendors. During his address to those attending the meeting, Jaitley said national security was paramount concern for the government.

He added that all hurdles and bottlenecks in the procurement process should be addressed expeditiously so that the pace of the acquisition is not stymied.

The DAC also approved the purchase of equipment for special operations for the Navy which remained classified.

Sources said it is basically for the elite Naval commandos Marcos.

The decision for the purchase of torpedos for the scorpene submarines and heavy calibre guns were put off today on technical grounds, sources said,adding that they are likely to be cleared soon.

The DAC was set up in 2001 as part of the post-Kargil reforms in defence sector.

The council approves the long-term integrated perspective plan for the forces, accords acceptance of necessity ( AON) to begin acquisition proposals, and has to grant its approval to all major deals through all their important phases.

It also has the power to approve any deviations in an acquisition, and recommends all big purchases for approval of the Cabinet committee on security.

In a recent conference of top commanders of the armed forces, Jaitley had said that the process of military acquisitions, which had slowed down due to "some controversies", will be speeded up with at least one meeting per month of DAC.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 3,2020

New Delhi, April 3: The total number of coronavirus cases in India on Friday climbed to 2301, including 156 cured and discharged and 56 deaths, said the Ministry of Health and Family Welfare.

At present, there are 2088 COVID-19 active cases in the country.

"A total number of COVID-19 positive cases rises to 2301 in India, including 156 cured/discharged, 56 deaths and 1 migrated," said the Health Department.

The highest number of positive cases of coronavirus was reported from Maharashtra at 335, including 16 deaths, followed by Tamil Nadu (309 and 6 deaths) and Kerala (286 and 2 deaths).

There are 219 coronavirus positive cases in the national capital, including 8 cured and discharged and 4 deaths.

The states which have crossed 100-mark for COVID-19 positive cases also include Andhra Pradesh (132), Karnataka (124), Rajasthan (133) and Telangana (107).

While 18 people were detected positive for coronavirus in Chandigarh, 70 cases were confirmed from Jammu and Kashmir and 14 from Ladakh.

In North-East, one COVID-19 case each has been confirmed from Mizoram and Assam, and two in Manipur.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 10,2020

New Delhi, Jun 10: The Enforcement Directorate (ED) on Wednesday brought back over 2,300 kg of polished diamonds and pearls worth Rs 1,350 crore of firms belonging to Nirav Modi and Mehul Choksi from Hong Kong, officials said.

Out of the 108 consignments that landed at Mumbai, 32 belong to overseas entities "controlled" by Modi while the rest are of Mehul Choksi firms.

Both the businessmen are being probed by the ED under the Prevention of Money Laundering Act (PMLA) in connection with an over USD 2 billion alleged bank fraud at a PNB branch in Mumbai.

The valuables include polished diamonds, pearls and silver jewellery, and is worth Rs 1,350 crore. 

The ED completed "all legal formalities" with authorities in Hong Kong to bring back these valuables, the agency said.

These will formally seized under the PMLA now, it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.